Loading company…
Scala Biodesign uses computational tools to design proteins for pharmaceutical and other applications.
Founded in 2022 and based in Tel Aviv, Israel, Scala Biodesign develops proteins using an AI-based computational platform. Its protein designs can be used in medicine, food technology, and industrial applications, including vaccines and enzymes. The company raised ILS 15 million in grant funding from Israel Innovation Authority in March 2026.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in